Evan Levow Pennsylvania DUI Attorney |
Drug DUI / DAI Prosecution
In Commonwealth v. Etchison, 916 A.2d 1169 (Pa.Super.2007), the
defendant consented to blood tests which revealed the presence of
alcohol (.05% BAC); a subsequent drug screening indicated 53 nanograms
of metabolites of cannabinoids as well. There was insufficient evidence
to convict him under section 3802(d)(2) because the Commonwealth's
expert witness, a toxicologist, testified on cross-examination that the
presence of metabolites is not an indication of present impairment, but
only that a substance was ingested sometime previously. Because the
expert failed to offer an opinion that the defendant was under the
influence of the substance (marijuana) at the time he drove, let alone
that he was under the influence to a degree that impaired his ability
to safely drive, the conviction could not stand. Marijuana, is a
fat-soluble drug that can stay metabolized in the blood months after
its consumption.
In order to convict under section 3208(d)(2), the Commonwealth only had
to prove that the defendant was "under the influence of a drug to a
degree that impairs" his or her ability to safely driver or operate a
vehicle. See Commonwealth v. Collins, 810 A.2d 698 (Pa.Super.2002)
(where defendant's urine sample "tested positive for phencyclidine or
PCP," she was properly convicted of driving under influence of
controlled substance in violation of 75 Pa.C.S.A. sec. 3731(a)(2), the
predecessor of section 3802(d)(2)). Section 3802(d)(2) does not require
that any amount or specific quantity of the drug be proven in order to
successfully prosecute under that section.
|